세계의 스마트 약물전달 시스템 시장 보고서(2025년)

Smart drug delivery systems encompass advanced technologies aimed at enhancing the efficacy, safety, and targeted delivery of pharmaceutical compounds within the body. These systems utilize diverse approaches to regulate drug release, improve bioavailability, and minimize adverse effects.

The primary products within smart drug delivery systems include connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and other related devices. Connected inhalers, for instance, are electronic monitoring systems integrated into inhalers, which track drug usage and may provide feedback on device technique. These systems find applications across various therapeutic areas such as metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and more. They can deliver drugs via different modes including injectable, inhalation, and oral routes, and cater to a range of end users including hospitals, clinics, home care settings, ambulatory care facilities, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides smart drug delivery systems market statistics, including smart drug delivery systems industry global market size, regional shares, competitors with smart drug delivery systems market share, detailed smart drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. This smart drug delivery systems market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $12.65 billion in 2024 to $15.06 billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to increasing demand for drug delivery systems, rising patient compliance, rising prevalence of chronic diseases, increasing personalized medicine, and need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $29.19 billion in 2029 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to growing burden of non-communicable diseases, increased focus on precision medicine, the rise of theragnostic, growing demand for non-invasive drug delivery methods, and increasing healthcare expenditure. Major trends in the forecast period include miniaturization and microfabrication technologies, advancements in material science, integration of artificial intelligence (AI) and machine learning (ML), development of nano-sized drug delivery systems, and integration of IoT and wearable technology.

The forecast of 18.0% growth over the next five years reflects a modest reduction of 1.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of precision-dose therapies by inflating prices of smart drug delivery systems developed in Germany and Switzerland, resulting in delayed chronic disease management and higher specialty pharmacy costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of chronic diseases is expected to drive the expansion of the smart drug delivery systems market. Chronic diseases are long-term health conditions that develop gradually and are often caused by a combination of factors. The increasing prevalence of these diseases is influenced by aging populations, environmental factors, and disparities in healthcare access. Smart drug delivery systems present a promising solution for managing chronic diseases by improving medication effectiveness and enhancing patient adherence. For example, a January 2023 report from the National Library of Medicine, a US-based medical library, projects that by 2050, 142.66 million people in the United States will have at least one chronic illness, representing a 99.5% increase from 71.522 million in 2020. As a result, the rising prevalence of chronic diseases is driving growth in the smart drug delivery systems market.

Key players in the smart drug delivery systems market are focused on developing innovative reusable drug delivery devices to revolutionize drug administration. One such device is Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of medication. Unlike single-use devices, Qfinity can be utilized for multiple injections, reducing waste and offering environmental benefits. For instance, Jabil Inc. launched Qfinity in May 2022, featuring the capability to handle over 100 injections per device and accommodating various pre-filled cartridges. The device not only reduces the carbon footprint per injection but also offers versatility in handling different drug volumes and viscosities. Additionally, the connected version, Qfinity+, enables remote monitoring of patient care and compliance through built-in sensors and electronics, ensuring connectivity without compromising ease of use.

In October 2023, Novo Nordisk A/S strengthened its position in the smart drug delivery systems market through the acquisition of Biocorp Production SA for $164.5 million. This strategic move aims to augment Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, exemplified by Mallya, a smart add-on device for pen injectors. Biocorp, a France-based designer and manufacturer of medical devices and drug delivery systems, brings expertise in connected devices that align with Novo Nordisk's focus on advancing drug delivery technologies to enhance patient care and treatment outcomes.

Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation

North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors; Other Products
• 2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders; Other Therapeutic Areas
• 3) By Drug Delivery Mode: Injectable; Inhalation; Oral
• 4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings; Other End-Users
• Subsegments:
• 1) By Connected Inhalers: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs)
• 2) By Connected Autoinjectors: Single-Dose Autoinjectors; Multi-Dose Autoinjectors
• 3) By Connected Pen Injectors: Insulin Pen Injectors; Biologic Pen Injectors
• 4) By Connected Wearable Injectors: Insulin Wearable Injectors; Infusion Pump Wearable Injectors
• 5) By Add-On Sensors: Glucose Monitoring Sensors; Medication Adherence Sensors; Temperature Sensors
• 6) By Other Products: Smart Syringes; Smart Patches; Smart Implants
• Companies Mentioned: Pfizer Inc; Johnson & Johnson; Bayer AG; Abbott Laboratories; Novartis International AG; Medtronic plc; Eli Lilly and Company; Amgen Inc; Novo Nordisk; Merck Group; Becton Dickinson and Company; Stryker Corporation; Baxter International Inc; Boston Scientific Corporation; Biogen Inc; Vertex Pharmaceuticals Incorporated; Phillips-Medisize Corporation; ResMed Inc; West Pharmaceutical Services Inc; Insulet Corporation; Owen Mumford Ltd; Sonceboz; H&T Presspart Manufacturing Ltd; E3D Elcam Drug Delivery Devices; CeQur Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Drug Delivery Systems Market Characteristics

3. Smart Drug Delivery Systems Market Trends And Strategies

4. Smart Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Smart Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Smart Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Smart Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Smart Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Smart Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Smart Drug Delivery Systems Total Addressable Market (TAM)

6. Smart Drug Delivery Systems Market Segmentation

• 6.1. Global Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Connected Inhalers
• Connected Autoinjectors
• Connected Pen Injectors
• Connected Wearable Injectors
• Add-On Sensors
• Other Products
• 6.2. Global Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metabolic Disorders
• Neurological Disorders
• Respiratory Disorders
• Hormonal Disorders
• Other Therapeutic Areas
• 6.3. Global Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Inhalation
• Oral
• 6.4. Global Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Care
• Ambulatory Care Settings
• Other End-Users
• 6.5. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dry Powder Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)
• 6.6. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Autoinjectors
• Multi-Dose Autoinjectors
• 6.7. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Pen Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Pen Injectors
• Biologic Pen Injectors
• 6.8. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Wearable Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Wearable Injectors
• Infusion Pump Wearable Injectors
• 6.9. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Add-On Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucose Monitoring Sensors
• Medication Adherence Sensors
• Temperature Sensors
• 6.10. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Smart Syringes
• Smart Patches
• Smart Implants

7. Smart Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Smart Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Smart Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Drug Delivery Systems Market

• 8.1. Asia-Pacific Smart Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Drug Delivery Systems Market

• 9.1. China Smart Drug Delivery Systems Market Overview
• 9.2. China Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Drug Delivery Systems Market

• 10.1. India Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Drug Delivery Systems Market

• 11.1. Japan Smart Drug Delivery Systems Market Overview
• 11.2. Japan Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Drug Delivery Systems Market

• 12.1. Australia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Drug Delivery Systems Market

• 13.1. Indonesia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Drug Delivery Systems Market

• 14.1. South Korea Smart Drug Delivery Systems Market Overview
• 14.2. South Korea Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Drug Delivery Systems Market

• 15.1. Western Europe Smart Drug Delivery Systems Market Overview
• 15.2. Western Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Drug Delivery Systems Market

• 16.1. UK Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Drug Delivery Systems Market

• 17.1. Germany Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Drug Delivery Systems Market

• 18.1. France Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Drug Delivery Systems Market

• 19.1. Italy Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Drug Delivery Systems Market

• 20.1. Spain Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Drug Delivery Systems Market

• 21.1. Eastern Europe Smart Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Drug Delivery Systems Market

• 22.1. Russia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Drug Delivery Systems Market

• 23.1. North America Smart Drug Delivery Systems Market Overview
• 23.2. North America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Drug Delivery Systems Market

• 24.1. USA Smart Drug Delivery Systems Market Overview
• 24.2. USA Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Drug Delivery Systems Market

• 25.1. Canada Smart Drug Delivery Systems Market Overview
• 25.2. Canada Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Drug Delivery Systems Market

• 26.1. South America Smart Drug Delivery Systems Market Overview
• 26.2. South America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Drug Delivery Systems Market

• 27.1. Brazil Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Drug Delivery Systems Market

• 28.1. Middle East Smart Drug Delivery Systems Market Overview
• 28.2. Middle East Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Drug Delivery Systems Market

• 29.1. Africa Smart Drug Delivery Systems Market Overview
• 29.2. Africa Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Smart Drug Delivery Systems Market Competitive Landscape
• 30.2. Smart Drug Delivery Systems Market Company Profiles
  • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Smart Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Eli Lilly and Company
• 31.3. Amgen Inc
• 31.4. Novo Nordisk
• 31.5. Merck Group
• 31.6. Becton Dickinson and Company
• 31.7. Stryker Corporation
• 31.8. Baxter International Inc
• 31.9. Boston Scientific Corporation
• 31.10. Biogen Inc
• 31.11. Vertex Pharmaceuticals Incorporated
• 31.12. Phillips-Medisize Corporation
• 31.13. ResMed Inc
• 31.14. West Pharmaceutical Services Inc
• 31.15. Insulet Corporation

32. Global Smart Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Drug Delivery Systems Market

34. Recent Developments In The Smart Drug Delivery Systems Market

35. Smart Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Smart Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Smart Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Smart Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer